← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
AD fine-mapping identifies causal variants in microglia-spec (TREM2) — 0.00 NAD+-SIRT1-H3K9me3 restoration enables true senescence rever (SIRT1) — 0.00 XOR+ stress-responsive astrocytes represent a novel AD-assoc (XOR) — 0.00 Rare TREM2-TYROBP pathway variants complement standard PRS b (PLCG2) — 0.00 Tissue-specific interactome destabilization drives phenotype (%s) — 0.00 Glucosylceramide accumulation nucleates alpha-synuclein aggr (GBA) — 0.00 Projection-specific vulnerability to complement-mediated syn (C1QA) — 0.00 O-GlcNAcylation at T212 competes with phosphorylation to red (OGT) — 0.00 Gut-derived butyrate reprograms microglia for amyloid cleara (HDAC2) — 0.00 H2S/butyrate imbalance drives enteric alpha-synuclein pathol (SNCA) — 0.00 Heparan sulfate proteoglycan binding selectivity determines (SDC3 (Syndecan-3)) — 0.00 Convergent NF-κB enhancers across diverse priming stimuli sh (BRD4) — 0.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.92 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.91
Add
|
× C9orf72 ASO Treatment Rev × Axonal Transport Defect:
C9orf72 · neurodegeneration · -
Composite 0.720
Price $0.72
Evidence For 0
Evidence Against 0
Antisense oligonucleotides targeting C9orf72 hexanucleotide repeat expansion reduce toxic DPR proteins and RNA foci, restoring nuclear TDP-43 localization and splicing function. This is the strongest hypothesis based on genetic prevalence (~40% familial ALS, ~25% FTD), active clinical trial data (NCT04165729), and mechanistic link between repeat transcripts and downstream TDP-43 pathology. Key unresolved questions include the relative contribution of haploinsufficiency vs. gain-of-function and w
C9orf72 · neurodegeneration · -
Composite 0.660
Price $0.66
Evidence For 0
Evidence Against 0
## Mechanistic Overview
Axonal Transport Defect: C9orf72 hexanucleotide expansion impairs retrograde autophagosome transport in motor neuron axons starts from the claim that modulating C9orf72 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Axonal Transport Defect: C9orf72 hexanucleotide expansion impairs retrograde autophagosome transport in motor neuron axons starts from the claim that modulating
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
C9orf72 Autophagy Unspecified Mechanism neurodegeneration
Convergent signals
C9orf72 recurs across 2 selected hypotheses with aligned directionality in autophagy, unspecified mechanism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 11/11
dimensions won
C9orf72 ASO Treatment Reverses TDP-43 Pa
2/11
dimensions won
Axonal Transport Defect: C9orf72 hexanuc
Radar Chart — 10 Dimensions
Score Breakdown
Dimension C9orf72 ASO Treatment Reverses Axonal Transport Defect: C9orf Mechanistic 0.820 0.620 Evidence 0.880 0.750 Novelty 0.650 0.600 Feasibility 0.780 0.720 Impact 0.920 0.680 Druggability 0.850 0.480 Safety 0.720 0.450 Competition 0.700 0.700 Data 0.850 0.820 Reproducible 0.800 0.750 KG Connect 0.500 0.500
Evidence C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD No evidence citations yet
Axonal Transport Defect: C9orf72 hexanucleotide expansion im No evidence citations yet
Debate Excerpts C9orf72 ASO Treatment Reverses TDP-43 Pathology in 4 rounds · quality: 0.77
Theorist # Therapeutic Hypotheses in Neurodegeneration
---
## Hypothesis 1: TREM2 Microglial Activation as Therapeutic Target in Alzheimer's Disease
**Title:** Enhancing TREM2-dependent microglial phagocyto...
Skeptic # Critical Evaluation of Neurodegeneration Therapeutic Hypotheses
---
## Hypothesis 1: TREM2 Microglial Activation
**Original Confidence: 0.78 → Revised: 0.62**
### Weak Links
- **Dose-dependency a...
Domain Expert # Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
## Analytical Framework
This assessment evaluates each hypothesis across five domains:
1. **Druggability** — tractability of the ta...
Synthesizer {
"ranked_hypotheses": [
{
"title": "C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD",
"description": "Antisense oligonucleotides targeting C9orf72 hexanucleotide repeat e...
Axonal Transport Defect: C9orf72 hexanucleotide ex 4 rounds · quality: 0.81
Theorist # Therapeutic Hypotheses: Neuron-Specific Autophagy Defects in ALS
---
## Hypothesis 1: Axonal Transport Defect in Autophagosome Maturation
**Title:** C9orf72 hexanucleotide expansion impairs retro...
Skeptic # Critical Evaluation of ALS Neuron-Specific Autophagy Hypotheses
---
## Hypothesis 1: Axonal Transport Defect (C9orf72/RAB7/Dynein)
### Weak Links
- **Causal direction ambiguous**: Axonal autophag...
Domain Expert # Feasibility Assessment: ALS Neuron-Specific Autophagy Hypotheses
---
## Summary Comparison Matrix
| Domain | H1: Axonal Transport (C9orf72/RAB7) | H2: OPTN/TBK1 Mitophagy | H3: TDP-43 SNARE Fusio...
Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "VCP/p97 ATPase mutations impair extraction of ubiquitinated autophagy substrates, causing proteasome-autophagy flux obstruction",
"descri...
Price History Overlay